Elevate Your Testosterone

Testosterone Replacement Therapy (TRT) is a treatment for men with low testosterone levels, a condition known as hypogonadism. Symptoms of hypogonadism can include decreased libido, fatigue, and loss of muscle mass. To qualify for TRT, you need to have low serum testosterone levels (below 300 to 350 ng/dL) on two separate morning tests and show symptoms of hypogonadism. TRT comes in different forms, such as topical gels and intramuscular injections, and the choice depends on factors like cost and your preference. While TRT can effectively improve symptoms and enhance quality of life, it requires careful selection, shared decision-making with your doctor, and close monitoring due to potential risks. Studies have shown that TRT can help improve symptoms and quality of life in men with low testosterone levels, but there are concerns about possible cardiovascular risks and long-term safety. Guidelines for TRT emphasize the need for personalized treatment plans and following clinical recommendations to avoid misuse. Despite some controversies, TRT is a commonly used treatment for hypogonadism, with ongoing research to better understand its benefits and risks.

KYZATREX® testosterone therapy is administered orally, in pill form. This method is designed to be convenient and maintain stable testosterone levels in the body. Oral testosterone undecanoate is effective for increasing testosterone levels in individuals with hypogonadism. Compared to traditional methods like injections, patches, or gels, the oral form is less invasive and can improve compliance and comfort [1].

The time it takes to see results from KYZATREX® testosterone therapy can vary depending on the specific outcomes being measured and the individual patient's response. Improvements in libido and sexual function can begin within the first few weeks of therapy. Enhancements in mood, energy levels, and overall sense of well-being typically become noticeable within the first 1-3 months, along with increases in muscle mass and strength. Improvements in bone density and reductions in the risk of osteoporosis generally become noticeable after 3-6 months of consistent therapy, and changes in body composition, such as a reduction in fat mass and an increase in lean muscle mass, typically become more evident after several months. For individuals with type 2 diabetes, improvements in glycemic control, such as reductions in HbA1c levels, may take up to 6-12 months to become significant. Positive effects on cardiovascular health, such as improved lipid profiles, may also take several months to a year to become apparent. Long-term benefits, including enhancements in cognitive function, memory, processing speed, and overall quality of life, are often observed with extended therapy. It is important to note that individual responses to TRT can vary, and regular monitoring by a healthcare provider is essential to ensure optimal dosing and manage any potential side effects. Adjustments to the therapy may be necessary based on the patient's response and any side effects experienced. In summary, while some benefits of Kyzatrex testosterone therapy can be observed within the first few weeks, most significant improvements in symptoms and overall health typically occur over several months of consistent treatment. Regular follow-up with a healthcare provider is crucial to achieving the best outcomes [1][2].

KYZATREX® testosterone therapy can offer several benefits for individuals with testosterone deficiency. It can improve sexual function by enhancing libido and erectile function, and it can boost mood and emotional well-being by alleviating symptoms of depression, irritability, and fatigue. TRT can also increase muscle mass and strength, improve bone density, and help prevent osteoporosis. For individuals with type 2 diabetes, TRT can improve glycemic control and insulin sensitivity. Additionally, TRT may positively impact cardiovascular health, cognitive functions like memory and processing speed, and overall quality of life. However, TRT should be administered under medical supervision, with regular monitoring to ensure safety and manage potential risks such as increased red blood cell count and cardiovascular concerns [1][2][3][4][5].

KYZATREX® testosterone therapy can be used to treat erectile dysfunction (ED), particularly in men with low testosterone levels (hypogonadism). Studies show that testosterone therapy can significantly improve ED symptoms in hypogonadal men, with 91.9% of young men with organic ED reporting improvement after therapy [1]. Combining testosterone therapy with PDE5 inhibitors, like sildenafil, has proven effective for men who do not respond to PDE5 inhibitors alone, restoring erectile function in 70% of diabetic participants [2]. Long-term testosterone therapy has shown benefits in improving erectile function in men with functional hypogonadism and obesity, with significant improvements noted over up to 13 years [5]. Testosterone therapy has also been effective in men with venous leakage, with some reporting significant improvement within 12-20 weeks of treatment [3]. Additionally, in men with type 2 diabetes and hypogonadism, long-acting testosterone undecanoate improved sexual function and quality of life, including better IIEF scores [4]. Regular monitoring and a tailored approach by healthcare providers are essential to maximize benefits and manage potential risks.

KYZATREX® may cause a small increase in 24-hour ambulatory systolic blood pressure, especially in those on antihypertensive therapy. Diastolic blood pressure and heart rate changes are minimal. Other potential side effects include headaches, mood changes, and increased red blood cell count. Monitoring is recommended for patients with hypertension or those on antihypertensive drugs to manage potential risks [1][2].

Yes, if you experience any side effects or have concerns during your treatment, contact our support immediately. We provide continuous support to ensure your therapy is as effective and comfortable as possible. If you experience any side effects, contact your medical provider right away. Depending on the nature and severity of the side effects, your provider may adjust your treatment plan, which could include altering the dosage or frequency of your medication. Any changes in your prescription will be reflected in how your refills are processed.

), has been shown to increase blood pressure, particularly in men already on antihypertensive therapy [2]. Patients with pre-existing hypertension or cardiovascular conditions should be closely monitored, as TRT can be associated with higher cardiovascular risks, including an increased risk of ischemic heart disease and other cardiovascular events [7]. While some studies suggest that TRT does not increase the risk of prostate cancer recurrence or death after treatment for localized disease [1], it is generally contraindicated in men with advanced prostate cancer [5]. Regular monitoring of prostate-specific antigen (PSA) levels is recommended for men undergoing TRT [4], and TRT can exacerbate symptoms of benign prostatic hyperplasia (BPH), leading to urinary retention and other complications [6]. Additionally, TRT can increase red blood cell count, leading to polycythemia, which can increase the risk of thromboembolic events, necessitating regular monitoring of hematocrit levels. Oral testosterone formulations, including KYZATREX®, can have hepatotoxic effects, so patients with pre-existing liver conditions should use TRT with caution and under strict medical supervision. TRT can also worsen sleep apnea [6], suppress spermatogenesis, leading to reduced fertility [3], and, although rare, increase the risk of male breast cancer [6]. It is crucial for patients to undergo a thorough medical evaluation and engage in shared decision-making with their healthcare provider to weigh the benefits and risks of TRT. Regular monitoring and follow-up are essential to ensure safety and efficacy.

KYZATREX® appears to be a safe and effective option for testosterone replacement therapy in older men. Studies show that it has a stable cardiovascular profile with minimal increases in blood pressure and heart rate. It effectively increases testosterone levels and improves well-being without significant adverse effects [2]. However, it's important for older men to monitor their cardiovascular and prostate health regularly while on TRT. Consulting with a healthcare provider to discuss individual risks and benefits is crucial [1][3][4].

KYZATREX® is primarily designed for testosterone replacement therapy in men, and its safety for older women is not well-documented. While testosterone therapy for women can benefit sexual function, bone health, and possibly protect against breast cancer, it remains controversial and lacks FDA approval. The cardiovascular risks and long-term safety are still debated. Older women considering testosterone therapy should consult a healthcare provider to discuss potential risks and benefits and explore approved options tailored to their needs [1][2][3][4].

KYZATREX® (oral testosterone) can slightly raise blood pressure, especially in people on blood pressure medication, with little effect on heart rate [1]. Intranasal testosterone gel (Natesto) has minimal impact on blood tests and low risk of increasing red blood cell count [6]. Intramuscular testosterone cypionate raises red blood cell levels more significantly, which can be risky [2][6]. Transdermal testosterone gel and long-acting intramuscular testosterone don't significantly increase heart problems [3][5]. Overall, KYZATREX® works well but needs blood pressure monitoring, especially for those with high blood pressure [1][4][5].

When you start your treatment, your prescription is generated after your first consultation and sent electronically to one of our partnered pharmacies. Your initial prescription typically includes a 30-day supply (120 tablets) with two refills.

After the initial period, refills are processed automatically. You'll receive communication about refilling your prescription when necessary.

Your medication will be refilled automatically. After the initial 30-day supply, the subsequent refills are scheduled to ensure there is no interruption in your therapy. The refills are processed 25 days after your initial and each subsequent visit, aligning with your treatment plan.

After the initial prescription and two refills, you will need to be reassessed by your medical provider. This will align with your scheduled follow-up visits. During these visits, your medical provider will review your progress and lab results to determine if your prescription should be continued or adjusted.

Once your refill is processed, the pharmacy will ship your medication directly to the address that you provide. You do not need to take any action to initiate the shipping process; however, ensuring your address details are current in our system will help avoid any delivery issues.

Manual refill requests are not necessary and are not encouraged, as they can disrupt the carefully planned treatment protocol. If you believe you are running low on your medication due to unforeseen circumstances, please contact our support team to discuss your situation.

If you encounter any issues with your refill, such as not receiving it on time or receiving incorrect quantities, please contact our customer support immediately. Our team is here to ensure your treatment proceeds smoothly and will help resolve any issues promptly.

To schedule routine lab work, visit LabCorp's website. Select "Routine Lab Work," then choose a lab. Finally, enter your zip code in the search bar to find a nearby location.

You will need your personal details and contact information.

Yes, after selecting the lab location, you can choose an available date and time from the calendar.

You indicate whether you are fasting by selecting "Yes" or "No" during the appointment scheduling process.

You will choose the “I have already paid or someone else is responsible” option as your payment with us covers your labs.

After reviewing all the entered information, click "Create Appointment". You will receive a confirmation screen with your appointment details.

Initial lab tests are conducted at the start, followed by additional tests at 90, 180 days, and then every 180 days.

Follow the instructions sent via email for scheduling lab work at designated LabCorp facilities. You must ensure all scheduled tests are completed as instructed.

Labs include tests for T/Free T, CBC, SHBG, PSA, and Estradiol.

If you miss a dose of KYZATREX®, take the missed dose as soon as possible if you remember shortly after. However, if it is nearly time for your next scheduled dose, skip the missed dose and do not take a double dose to make up for it. Continue with your regular dosing schedule after taking the missed dose or skipping it. If you are unsure about what to do after missing a dose, or if you miss multiple doses, contact your healthcare provider for specific advice. Always refer to the specific instructions provided by your healthcare provider or the medication's prescribing information.

The normal ranges for testosterone levels can vary based on the method of measurement and the population being studied. For adult men, total testosterone levels typically range from 264 to 916 ng/dL in healthy, non-obese men aged 19 to 39 years, with calculated free testosterone levels ranging from 0.23 to 0.63 nmol/L [1][6]. In women, the upper reference range limit for total testosterone is less than 1.7 nmol/L. For premenopausal women, the estimated 5th and 95th percentiles for a 30-year-old woman are 15-46 ng/dL (520-1595 pmol/L) for total testosterone, 1.2-6.4 pg/mL (4.16-22.2 pmol/L) for free testosterone, 1.3-5.6 pg/mL (4.5-19.4 pmol/L) for calculated free testosterone, and 1.12-7.62 ng/dL (38.8-264.21 pmol/L) for bioavailable testosterone, with SHBG levels ranging from 18-86 nmol/L [4]. In specific populations, such as older men with low or low-normal testosterone levels, the range is defined as total testosterone between 100 to 400 ng/dL or free testosterone less than 50 pg/mL [2][5]. For aging men with low-normal testosterone levels, the range is 6-14 nmol/L [3]. The method of measurement, such as tandem mass spectrometry, can affect reference ranges due to its accuracy, with harmonized values for total testosterone in men aged 19 to 39 years being 264 to 916 ng/dL [1][6]. In summary, the normal ranges for testosterone levels are crucial for diagnosing conditions like hypogonadism and tailoring appropriate treatments. For adult men, total testosterone levels typically range from 264 to 916 ng/dL, while for women, the upper limit is less than 1.7 nmol/L, with variations based on age, sex, and specific populations.

T/Free T refers to the ratio of total testosterone (T) to free testosterone (Free T) in the blood. This ratio is used to assess the levels of testosterone that are biologically active and available for use by the body, as opposed to testosterone that is bound to proteins and not readily available [6]. Total testosterone includes all the testosterone in the blood, both bound and unbound, with most of it bound to proteins such as sex hormone-binding globulin (SHBG) and albumin, making it biologically inactive. Free testosterone, on the other hand, is the fraction of testosterone that is not bound to any proteins and is therefore biologically active. This form of testosterone can enter cells and exert its effects on various tissues [5]. The T/Free T ratio is important because it provides a more accurate picture of the hormonal status and potential clinical conditions than total testosterone alone [3]. For instance, in conditions like hypogonadism, the total testosterone levels might be normal, but the free testosterone levels could be low, indicating a deficiency in biologically active testosterone [1]. Several methods are used to measure free testosterone, including equilibrium dialysis (considered the gold standard but not suitable for routine clinical use), direct immunoassay (which may not be as accurate) [6], calculated free testosterone derived from total testosterone and SHBG concentrations [7], and the Free Androgen Index (FAI), which is the ratio of total testosterone to SHBG, providing an estimate of free testosterone levels [4]. Accurate measurement of free testosterone is crucial for diagnosing and managing conditions like hypogonadism, polycystic ovary syndrome (PCOS), and other endocrine disorders [2]. Standardization and validation of these measurement methods are essential for reliable clinical assessment [6].

A Complete Blood Count (CBC) is a common and comprehensive blood test that evaluates overall health and detects a wide range of disorders, including anemia, infection, and many other diseases. The CBC measures several components and features of the blood, including white blood cells (WBCs), red blood cells (RBCs), and platelets. WBCs are part of the immune system and help fight infections; the CBC measures the total number of WBCs and can also provide a differential count, which breaks down the different types of white blood cells (e.g., neutrophils, lymphocytes) [1]. RBCs carry oxygen from the lungs to the rest of the body and return carbon dioxide to the lungs to be exhaled. The CBC measures the total number of RBCs and several related parameters, such as hemoglobin (Hb), hematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), and red cell distribution width (RDW) [2]. Platelets are small cell fragments that play a crucial role in blood clotting, and the CBC measures the number of platelets as well as additional parameters such as mean platelet volume (MPV) and platelet distribution width (PDW) [3][4]. The CBC is a valuable diagnostic tool in various clinical settings. Elevated WBC counts can indicate infection or inflammation, while specific patterns in the differential count can help identify the type of infection (e.g., bacterial vs. viral) [1]. Low RBC counts, hemoglobin, and hematocrit levels can indicate anemia, while MCV, MCH, and MCHC values can help determine the type of anemia [2]. Abnormalities in the number or appearance of blood cells can indicate blood disorders such as leukemia or clotting disorders [4][5]. Additionally, CBC parameters can be useful in monitoring chronic conditions like diabetes, cardiovascular diseases, and rheumatic disorders [3][4]. The CBC is relatively inexpensive, widely available, and provides a broad overview of a patient's hematological health. While the CBC is a powerful tool, it is not specific for any one disease and must be interpreted in the context of the patient's overall clinical picture and other diagnostic tests [2][4].

Sex hormone-binding globulin (SHBG) is a glycoprotein that plays a crucial role in the transport and regulation of sex hormones in the bloodstream. It primarily binds to androgens, such as testosterone, and estrogens, thereby regulating their bioavailability and activity in the body. SHBG binds to sex hormones, particularly testosterone and estradiol, and transports them in the bloodstream. This binding regulates the amount of free (bioavailable) hormones that can interact with target tissues and exert biological effects. By binding to sex hormones, SHBG controls their access to tissues and cells. Only the unbound (free) fraction of these hormones is biologically active and can interact with hormone receptors [7]. Additionally, SHBG levels have been associated with various metabolic and renal functions. For instance, lower SHBG levels have been linked to worse biometric, lipid, liver, and renal function parameters in women with polycystic ovary syndrome (PCOS) [6]. Moreover, SHBG levels have been found to be associated with kidney function in both men and women, with lower levels correlating with lower estimated glomerular filtration rate (eGFR) and higher risk of chronic kidney disease (CKD) [2][3][5]. SHBG is clinically relevant in various health contexts. Certain chemicals, such as hexaconazole, have been shown to interact with SHBG, potentially disrupting normal endocrine functions. Hexaconazole, a fungicide, has demonstrated stable molecular interaction with SHBG, which may interfere with the binding of natural hormones and lead to endocrine disruption [1]. Studies have shown that SHBG levels are positively associated with kidney function, with higher levels associated with better eGFR and lower risk of CKD in men [2][5]. In women, SHBG levels have also been linked to kidney function, although the associations can vary based on other factors such as age and metabolic health [3]. Additionally, SHBG levels are associated with lipid profiles and cardiometabolic health. Higher SHBG levels have been linked to better lipid profiles, including higher high-density lipoprotein cholesterol (HDL-C) and lower triglycerides and non-HDL cholesterol [4][6].

Prostate-Specific Antigen (PSA) is a protein produced by both normal and malignant cells of the prostate gland, commonly measured through a blood test. It is primarily used to screen for prostate cancer, monitor treatment effectiveness, and detect recurrence of the disease. PSA testing is a crucial tool for early detection of prostate cancer. Elevated levels of PSA in the blood can indicate the presence of prostate cancer, although other conditions such as benign prostatic hyperplasia (BPH) and prostatitis can also cause increased PSA levels [1][2]. Specific PSA thresholds guide clinical decisions. For example, PSA concentrations of ≤ 4.1 μg/L for men under 65 and ≤ 3.7 μg/L for men 65 and older can exclude advanced prostate cancer in patients without glandular inflammation. Conversely, PSA levels > 5.7 μg/L for men under 65 and > 6.1 μg/L for men 65 and older suggest the need for a biopsy [2]. Various factors can influence PSA levels and the likelihood of undergoing PSA testing. For example, men with a history of ischemic heart disease (IHD) are more likely to have been tested for PSA compared to those without IHD [1]. PSA levels are used to monitor the effectiveness of prostate cancer treatments. A significant decline in PSA levels during treatment with apalutamide and androgen deprivation therapy (ADT) is associated with longer survival and improved outcomes in patients with metastatic castration-sensitive prostate cancer [6]. After treatments like radical prostatectomy or radiation therapy, specific PSA thresholds are used to define biochemical recurrence. A PSA level of ≥ 0.2 ng/mL is commonly used to report biochemical relapse after radical prostatectomy, while a threshold of 2 ng/mL above the post-treatment nadir is used for external beam radiotherapy or brachytherapy [3][5]. False positive findings can occur in PSA testing, particularly with advanced imaging techniques like PET/CT scans using PSMA-targeting radiopharmaceuticals, which can complicate the interpretation of PSA levels post-treatment [4].

Estradiol (E2), also known as 17β-estradiol, is a steroid hormone and the primary form of estrogen in humans. It plays a crucial role in regulating reproductive and sexual functions in both females and males. In premenopausal women, estradiol is the most potent estrogen produced by the ovaries and is vital for maintaining fertility and secondary sexual characteristics. Estradiol binds to specific nuclear receptors in various tissues, including the reproductive tract, breast, pituitary, hypothalamus, liver, and bone, thereby activating the transcription of genes involved in reproductive and secondary sexual characteristics. Its functions extend beyond the reproductive system, influencing bone density, cardiovascular health, cognitive function, and skin health by promoting collagen production and maintaining skin thickness and moisture. In men, estradiol is produced from testosterone through a process called aromatization, where the enzyme aromatase converts testosterone to estradiol. Estradiol in men plays a role in maintaining bone density, modulating libido and erectile function, and contributing to cardiovascular health by affecting lipid metabolism and vascular function. When testosterone levels are low, there is less substrate for aromatase to convert into estradiol, leading to lower estradiol levels. This imbalance can contribute to symptoms associated with low testosterone, such as decreased libido, erectile dysfunction, reduced bone density, and mood disturbances. Hormone Replacement Therapy (HRT) can help normalize both testosterone and estradiol levels in men, but it is crucial to monitor estradiol levels to avoid potential complications like gynecomastia and cardiovascular issues. Elevated estradiol levels are a risk factor for certain cancers, including breast cancer, and can have environmental impacts, affecting aquatic life and potentially entering the human water supply. [1,2,3,4,5,6,7,8,9, 10]

Estradiol (E2), also known as 17β-estradiol, is a steroid hormone and the primary form of estrogen in humans. It plays a crucial role in regulating reproductive and sexual functions in both females and males. In premenopausal women, estradiol is the most potent estrogen produced by the ovaries and is vital for maintaining fertility and secondary sexual characteristics. Estradiol binds to specific nuclear receptors in various tissues, including the reproductive tract, breast, pituitary, hypothalamus, liver, and bone, thereby activating the transcription of genes involved in reproductive and secondary sexual characteristics. Its functions extend beyond the reproductive system, influencing bone density, cardiovascular health, cognitive function, and skin health by promoting collagen production and maintaining skin thickness and moisture. In men, estradiol is produced from testosterone through a process called aromatization, where the enzyme aromatase converts testosterone to estradiol. Estradiol in men plays a role in maintaining bone density, modulating libido and erectile function, and contributing to cardiovascular health by affecting lipid metabolism and vascular function. When testosterone levels are low, there is less substrate for aromatase to convert into estradiol, leading to lower estradiol levels. This imbalance can contribute to symptoms associated with low testosterone, such as decreased libido, erectile dysfunction, reduced bone density, and mood disturbances. Hormone Replacement Therapy (HRT) can help normalize both testosterone and estradiol levels in men, but it is crucial to monitor estradiol levels to avoid potential complications like gynecomastia and cardiovascular issues. Elevated estradiol levels are a risk factor for certain cancers, including breast cancer, and can have environmental impacts, affecting aquatic life and potentially entering the human water supply. [1,2,3,4,5,6,7,8,9, 10]

Certain lifestyle changes can significantly impact testosterone levels, particularly in aging men. Weight management is crucial; studies show that weight loss is associated with increased testosterone and sex hormone-binding globulin (SHBG) levels, while weight gain leads to a decrease in these hormones. Obesity-induced hypogonadism can be mitigated by weight loss, as shown by a meta-analysis indicating significant increases in testosterone levels in obese men who lost weight [1][3]. Dietary changes also play a role; the effects of low-carbohydrate diets on testosterone levels are mixed, with short-term increases in cortisol levels possibly negatively impacting testosterone, while high-protein, low-carbohydrate diets have been shown to decrease resting testosterone levels. Additionally, diets low in fat combined with exercise can reduce serum hormones, including testosterone, but may also reduce prostate cancer cell growth [2][7]. Regular exercise, especially resistance training and high-volume moderate-intensity exercise, has been shown to increase testosterone levels. A study found that higher volumes of exercise significantly increased testosterone and improved sexual function in obese men [9]. Combining exercise with dietary interventions, such as a very-low-calorie diet, enhances the benefits on testosterone levels and overall health by maintaining lean body mass and improving glucose tolerance [10]. Smoking cessation is also important, as quitting smoking is associated with a greater decline in testosterone levels compared to non-smokers, suggesting a direct impact of smoking on testosterone levels [1]. Metabolic and bariatric surgeries, such as Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG), significantly increase testosterone levels in men with obesity and improve inflammatory and endothelial biomarkers [4][6][8]. Managing comorbid conditions like metabolic syndrome and type 2 diabetes is also critical, as lifestyle interventions, including diet and exercise, can improve glycemic control and metabolic health, increasing testosterone levels [5]. Regular monitoring and consultation with healthcare providers are essential to tailor these interventions to individual needs.

Stopping KYZATREX® testosterone therapy should not be done abruptly or without medical supervision, even if you feel better. Consult your healthcare provider before making any changes, as sudden discontinuation can lead to the return of symptoms like fatigue, decreased libido, mood swings, and reduced muscle mass, as well as hormonal imbalances. If discontinuation is necessary, a gradual reduction in dosage under medical supervision is recommended. Regular follow-up appointments and monitoring are essential to manage discontinuation safely. Additionally, incorporating lifestyle changes such as weight management, regular exercise, a balanced diet, and stress reduction can help maintain health after stopping therapy. Always seek medical advice before altering your therapy regimen.

Please report any side effects to your medical provider immediately. They may adjust your treatment or take additional measures to manage side effects.

Upon visiting the page for the KYZATREX® Low-T program, if you choose to provide your email address, you'll receive a voucher valid for one month of free product which can be redeemed during the payment process.

In the event of a payment failure, you'll be notified via email for your next steps. Additionally, our support team will be informed and will reach out to you to assist in resolving the issue to prevent disruption in your treatment plan.

Once you've made a payment, the outcome will be communicated to you via email. Our platform uses Stripe for processing payments, and notifications are sent out for both successful transactions and failures.

The initial costs for the KYZATREX® program are $99 for walk-in labs or $129 for the at-home lab kit. If approved for the program based on the medical provider's analysis of your blood results, there is a recurring cost of $229 which includes the cost of medication and required maintenance lab tests (walk-ins) and doctor visits. The recurring cost will be $259 if you choose the at-home lab kit option. Walk-in labs from LabCorp are currently not available in New Jersey, Rhode Island, and Connecticut.

The initial payment will be authorized after checkout following your initial treatment protocol questionnaire.

‌Payment for refills is automatically authorized every month to the card linked to your Stripe account.